Clinical Trial Update: The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer [NA]

View source ↗

Summary

This document provides an update on an ongoing clinical trial evaluating the diagnostic value of FAPI PET/CT for staging newly diagnosed prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FAPI PET/CT (Fibroblast activation protein inhibitor PET tracer)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Prostate Cancer, Prostate Cancer Metastatic | NA | Status: NOT_YET_RECRUITING